Search
for
Sort by
Research 541–570 of 838
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Regenerative Effect of Intraovarian Injection of Activated Autologous Platelet Rich Plasma: Serum Anti-Mullerian Hormone Levels Measured Among Poor-Prognosis In Vitro Fertilization Patients
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Significant effects of mild endogenous hormonal changes in humans: considerations for low-dose testing.
- ANDROGENETIC ALOPECIA
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Polycystic ovarian syndrome
- Androgenetic Alopecia: In Vivo Models
- Identification and characterization of an antisense RNA transcript (gfg) from the human basic fibroblast growth factor gene.
- Is polycystic ovary syndrome a sexual conflict? A review
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Selenium and Polycystic Ovary Syndrome; Current Knowledge and Future Directions: A Systematic Review
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Congenital adrenal hyperplasia
- Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?
- Cross-sex hormone therapy in Australia: the prescription patterns of clinicians experienced in adult transgender healthcare
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Antiandrogen therapy for androgenetic alopecia
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Interventional studies for polycystic ovarian syndrome in children and adolescents
- Oligomenorrhoea in Exercising Women
- Controversies in plastic surgery: Suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment
- Androgen excess and post-reproductive health